Home Gender difference and determinants of C-reactive protein level in Korean adults
Article
Licensed
Unlicensed Requires Authentication

Gender difference and determinants of C-reactive protein level in Korean adults

  • Yong-Jae Lee , Jung-Hyun Lee , Youn-Ho Shin , Jong-Koo Kim , Hye-Ree Lee and Duk-Chul Lee
Published/Copyright: July 1, 2009

Abstract

Background: C-reactive protein (CRP) has emerged as an important predictor for cardiovascular disease (CVD). To facilitate clinical and public health interventions, CRP thresholds have been defined as follows: low-risk (<1.0 mg/L), average-risk (1.0–3.0 mg/L), and high-risk (>3.0 mg/L). However, these cut-off thresholds are based on distributions in Western populations, and do not distinguish between men and women.

Methods: We examined CRP distribution, gender difference, and determinants of CRP concentrations ranging from 0.02 mg/L to 10.0 mg/L, in 4923 Korean adults (2248 men; 2675 women) who received health checkups at Gangnam Severance Hospital from March 2006 to May 2007.

Results: The distribution of CRP was highly skewed toward lower concentrations. CRP was higher in men than women, and the cut-off thresholds for the high-risk tertile of CRP concentrations corresponded to 1.01 mg/L in men and 0.62 mg/L in women, based on the current study population. Age, male gender, cigarette smoking, physical activity, body mass index, total cholesterol, high density lipoprotein cholesterol, γ-glutamyltransferase, and uric acid were independently associated with CRP concentrations.

Conclusions: CRP distribution and gender difference in Korean adults were found to be different from previous Western studies, although similar risk factors influence CRP concentrations. Our results suggest that ethnicity and gender specific cut-off thresholds for CRP concentrations should be taken into consideration in CVD risk assessment.

Clin Chem Lab Med 2009;47:863–9.


Corresponding author: Duk-Chul Lee, MD, PhD, Department of Family Medicine, Yonsei University College of Medicine, 134 Sinchon-dong, Seodaemun-gu, Seoul, Korea Phone: +82-2-2228-2331, Fax: +82-2-362-2473,

Received: 2009-1-24
Accepted: 2009-4-20
Published Online: 2009-07-01
Published in Print: 2009-07-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Change through continuity
  3. EFCC and Labs are Vital announce an Award for Outcomes Research in Laboratory Medicine
  4. Review
  5. The prevalence and risk factors for gallstone disease
  6. Opinion Paper
  7. Measurement uncertainty of test kit results – the ELISA example
  8. Genetics and Molecular Diagnostics
  9. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters
  10. High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma
  11. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency
  12. The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer
  13. General Clinical Chemistry and Laboratory Medicine
  14. Evaluation of analytical performance of the Pathfast® cardiac troponin I
  15. Diagnostic performance of the ARCHITECT C-Peptide immunoassay
  16. Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection
  17. Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
  18. Therapeutic drug monitoring and drugs of abuse testing on the cobas® 6000 analyzer series: analytical performance under routine-like conditions
  19. Is serum γ-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon
  20. Reference Values and Biological Variations
  21. Gender difference and determinants of C-reactive protein level in Korean adults
  22. Cancer Diagnostics
  23. Quantitative telomerase activity in circulating human leukocytes: utility of real-time telomeric repeats amplification protocol (RQ-TRAP) in a clinical/epidemiological setting
  24. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers
  25. Letters to the Editor
  26. Hyperleukocytosis: pseudohyperkalaemia and other biochemical abnormalities in hyperleukocytosis
  27. Review of the prevalence of macroprolactinaemia in a South African hospital
  28. A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program
  29. Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions
  30. Doubt on prevention of false-positive results of cardiac troponin I by recentrifugation
  31. Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
Downloaded on 24.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.196/pdf
Scroll to top button